The immunohistochemical analysis of human MTC samples harboring RET somatic or germline mutations showed strong nuclear staining of different members of the NF-κB family [48], corroborating the notion that mutated RET could be responsible for NF-κB activation in MTCs [41]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.